treosulfan has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, E; Bielorai, B; Hutt, D; Jacoby, E; Malkiel, S; Somech, R; Toren, A | 1 |
| Beier, R; Bernardo, ME; Burroughs, L; Ewins, AM; Fraser, C; Gennery, AR; Gibson, B; Kalwak, K; Krol, L; Meyts, I; Morillo-Gutierrez, B; Müller, I; Rao, K; Schulz, A; Sedlacek, P; Slatter, M; Strahm, B; Sykora, KW; Talano, JA; Veys, P; Wachowiak, J; Woolfrey, A; Zaidman, I | 1 |
| Bernatowska, E; Chybicka, A; Gorczyńska, E; Heropolitanska-Pliszka, E; Kalwak, K; Klaudel-Dreszler, MA; Kurenko-Deptuch, M; Mikoluc, B; Pietrucha, B; Ussowicz, M; Wolska-Kusnierz, B | 1 |
1 trial(s) available for treosulfan and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience.
Topics: Acute Disease; Adolescent; Adult; Allografts; Blood Platelets; Busulfan; Child; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Neutrophils; Survival Rate; Transplantation Conditioning | 2016 |
2 other study(ies) available for treosulfan and Autosomal Recessive Chronic Granulomatous Disease
| Article | Year |
|---|---|
Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors.
Topics: Busulfan; Child; Child, Preschool; Graft vs Host Disease; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Neutrophils; Transplantation Conditioning | 2023 |
Treosulfan-based conditioning regimen in a second matched unrelated peripheral blood stem cell transplantation for a pediatric patient with CGD and invasive aspergillosis, who experienced initial graft failure after RIC.
Topics: Antineoplastic Agents, Alkylating; Aspergillosis; Busulfan; Child, Preschool; Graft Survival; Granulomatous Disease, Chronic; Humans; Male; Peripheral Blood Stem Cell Transplantation; Reoperation; Transplantation Conditioning | 2009 |